期刊文献+

孟鲁司特治疗儿童肺炎支原体感染所致咳嗽的疗效观察 被引量:6

Observation on efficacy of montelukast in the treatment of cough caused by Mycoplasma pneumoniae in children
下载PDF
导出
摘要 目的:观察孟鲁司特钠咀嚼片对儿童肺炎支原体(MP)感染所致咳嗽的疗效。方法:选取80例MP感染所致咳嗽儿童,在应用抗生素治疗的基础上,随机分成两组,治疗组和对照组。于治疗后3天、1周、2周观察咳嗽缓解情况。结果:随治疗时间延长,两组咳嗽缓解率不断增加,且治疗组缓解率明显高于对照组。结论:孟鲁司特钠可缩短咳嗽病程,促进咳嗽康复,疗效肯定。 Objective:To study the efficacy of montelukast in the treatment of cough caused by Mycoplasma pneumoniae in chil- dren.Methods:Select the 80 cases of chil- dren infected with cough caused by MP. They were randomly divided into 2 groups: the treatment group and the control group on the basis of antibiotic treatment.Make obser- vation on cough relief 3 days,one week,two weeks after treatment.Results:With the pro- longing of treatment,cough remission rates of the two groups increase continually,and the treatment group is significantly higher than the control group.Conclusions:Montelukast reduces courses of cough,promotes cough re- covery,which is effective,worthy of clinical promotion.
作者 陈琼华
出处 《中国社区医师(医学专业)》 2013年第22期33-34,共2页
关键词 孟鲁司特 肺炎支原体 咳嗽 儿童 montelukast mycoplasma pne- umoniae cough children
  • 相关文献

参考文献6

二级参考文献36

  • 1包瑛,雷春莲,史瑞明,周南.肺炎支原体下呼吸道感染及肺外并发症患儿外周血T细胞亚群检测及其临床意义[J].陕西医学杂志,2005,34(1):107-109. 被引量:10
  • 2王俊,韩晓华,杨柏松,尚云晓,刘春峰,蔡栩栩.肺炎支原体肺炎患儿血清及诱导痰中白细胞介素-4及γ-干扰素的测定[J].中国实用儿科杂志,2005,20(9):543-545. 被引量:44
  • 3Pefers S P. Leukotriene receptor antagonist in asthma therapy [ J ]. 2003,11 ( 1Suppl ) : s62-67.
  • 4Howarth P H, Salagean M, Dokic D. Allergic rhinitis : not purely a histamine-related disease [ J ]. Allergy, 2000,55Supp164 : 7-16.
  • 5Steinshamn S, Sandsund M, Sue-Chu M, et al. Effects of montelukast on physical performance and exercise economy in adult asthmatics with exercise-induced bronchoconstriction[J]. Scand J Med Sci Sports , 2002, 12(4):211-217.
  • 6Niewoehner DE. Montelukast improved pulmonary function and asthma-specific quality of life in aspirin-intolerant asthma[J]. ACP J Club, 2002, 137(1):20.
  • 7Zhang J, Yu C, Noonan G, et al. Effect of montelukast, a once-daily leukotriene receptor antagonist, on peak expiratory flow variability[J]. Clin Ther, 2002, 24(4):574-582.
  • 8Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresportsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor ( sIL-2R), IL-4, and soluble intercellular adhesion molecule 1(sICAM-1) in children with asthma[J]. J Allergy Clin Immunol, 2002, 109(2) :257 - 263.
  • 9Dempsey O J, Kennedy G, Lipworth BJ. Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukolriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma [ J ]. J Allergy Clin Immunol, 2002, 109(1):68-74.
  • 10Phipatanakul W, Nowak-Wegrzyn A, Eggleston PA, et al.The efficacy of montelukast in the treatment of cat allergen-induced asthma in children[J]. J Allergy Clin Immunol,2002, 109(5) :794 - 799.

共引文献122

同被引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部